Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -284.81% is 21% below its 3-year average of -236.19%, around the middle of its 3-year range (-670.38%–-83.79%).
As of the fiscal period ended Tuesday, June 30, 2026. 38.57% above its 12-month average of -463.65%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -284.81%.
RETURN ON INVESTED CAPITAL (ROIC)
-284.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-463.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-242.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+38.57%
CURRENT VS 3Y AVG
-17.63%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-699.02%
vs the sector median at left
Cadrenal Therapeutics, Inc. Common Stock
Market Cap
$3.53M
Return on Invested Capital (ROIC)
-284.81%
TTM Avg
-463.65%
3Y Avg
-242.12%
5Y Avg
N/A
Market Cap
$3.50M
Return on Invested Capital (ROIC)
-33.50%
TTM Avg
-18.16%
3Y Avg
-45.78%
5Y Avg
-36.63%
Market Cap
$3.50M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.49M
Return on Invested Capital (ROIC)
-45.77%
TTM Avg
-25.13%
3Y Avg
-754.36%
5Y Avg
-475.60%
Market Cap
$3.63M
Return on Invested Capital (ROIC)
-9.04%
TTM Avg
-9.04%
3Y Avg
-6.72%
5Y Avg
4.87%
Market Cap
$3.65M
Return on Invested Capital (ROIC)
-346.94%
TTM Avg
-467.60%
3Y Avg
-296.93%
5Y Avg
-277.74%
Market Cap
$3.65M
Return on Invested Capital (ROIC)
-130.12%
TTM Avg
-72.08%
3Y Avg
-61.96%
5Y Avg
-55.38%
Market Cap
$3.30M
Return on Invested Capital (ROIC)
-600.62%
TTM Avg
-217.41%
3Y Avg
-160.53%
5Y Avg
-160.53%
Market Cap
$3.28M
Return on Invested Capital (ROIC)
-9.72%
TTM Avg
-8.51%
3Y Avg
-19.00%
5Y Avg
-22.23%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $3.53M | -284.81% | -463.65% | -242.12% | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.50M | -33.50% | -18.16% | -45.78% | -36.63% |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -45.77% | -25.13% | -754.36% | -475.60% |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.63M | -9.04% | -9.04% | -6.72% | 4.87% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | -346.94% | -467.60% | -296.93% | -277.74% |
| Evogene Ltd. (EVGN)vs › | $3.65M | -130.12% | -72.08% | -61.96% | -55.38% |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | -600.62% | -217.41% | -160.53% | -160.53% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | -9.72% | -8.51% | -19.00% | -22.23% |
| MBody AI Ltd. (MBAI)vs › | $3.25M | -69.04% | -69.04% | -66.04% | -57.92% |
ROIC
-284.8%
ROE
-282.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -284.81% |
| 2026-03-31 | -670.38% |
| 2025-12-31 | -491.51% |
| 2025-09-30 | -536.56% |
| 2025-06-30 | -334.98% |
| 2025-03-31 | -214.83% |
| 2024-12-31 | -147.33% |
| 2024-09-30 | -232.86% |
| 2024-06-30 | -166.04% |
| 2024-03-31 | -83.79% |
| 2023-12-31 | -99.23% |
| 2023-09-30 | -85.10% |
| 2023-06-30 | -228.44% |
| 2023-03-31 | -164.97% |
